Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $1.2 billion.

  • Neurocrine Biosciences' Total Non-Current Liabilities rose 2034.69% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 2034.69%. This contributed to the annual value of $1.2 billion for FY2025, which is 2034.69% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Total Non-Current Liabilities of $1.2 billion as of Q4 2025, which was up 2034.69% from $1.1 billion recorded in Q3 2025.
  • Neurocrine Biosciences' 5-year Total Non-Current Liabilities high stood at $1.2 billion for Q4 2025, and its period low was $619.5 million during Q1 2021.
  • Its 4-year average for Total Non-Current Liabilities is $823.8 million, with a median of $777.5 million in 2023.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 1239.87% in 2024, then surged by 5657.03% in 2025.
  • Neurocrine Biosciences' Total Non-Current Liabilities (Quarter) stood at $663.0 million in 2021, then surged by 37.72% to $913.1 million in 2023, then rose by 5.44% to $962.8 million in 2024, then rose by 20.35% to $1.2 billion in 2025.
  • Its Total Non-Current Liabilities stands at $1.2 billion for Q4 2025, versus $1.1 billion for Q3 2025 and $985.4 million for Q2 2025.